J-STAGE トップ  >  資料トップ  > 書誌事項

肝臓
Vol. 51 (2010) No. 7 P 394-396

記事言語:

http://doi.org/10.2957/kanzo.51.394

短報

We investigated the efficacy of the triple treatment with telaprevir, pegylated interferon (PEG-IFN) and ribavirin for 12 weeks in treatment-naïve patients infected with hepatitis C virus (HCV) genotype 1b and high baseline viral loads. All of 10 cases became HCV-RNA negative during treatment. SVR rate attained to a high rate, 70% (7/10). Especially, SVR rate of females over 50 years old attained 100% (3/3). HCV RNA was lost from serum rapidly in patients infected with HCV-1b in high viral loads, and SVR rate of the triple treatment for 12weeks was high. Our results suggested that triple treatment with telaprevir, PEG-IFN and ribavirin could improve the efficacy in treatment-naïve patients.

Copyright © 2010 一般社団法人 日本肝臓学会

記事ツール

この記事を共有